Printer Friendly
The Free Library
14,678,741 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Heidelberg's Retina Module Offers New and Improved Methods for Evaluating Diabetic Macular Edema and Other Retina Conditions.


To download high-resolution, print-ready JPEG images, click on the thumbnail image above.

WARNING: these images are

very large (800K+)

Click here for caption

Photo Editors/Business Editors

NOTE TO MEDIA: Multimedia assets available

A photo is available at URL URL
 in full Uniform Resource Locator

Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program.
:

http://www.businesswire.com/cgi-bin/photo.cgi?pw.110603/bb3

VISTA, Calif.--(BUSINESS WIRE)--Nov. 6, 2003

Heidelberg Engineering, leaders in retinal imaging technology, continues to expand its product portfolio with the release of the new Retina Module for the Heidelberg Retina Tomograph II (HRT HRT
abbr.
hormone replacement therapy


Hormone replacement therapy (HRT)
Also called estrogen replacement therapy, this controversial treatment is used to relieve the discomforts of menopause.
 II).

The HRT II is an important part of the growing Heidelberg product line, with proven glaucoma applications that allow for earlier detection of disease and monitoring of its progression.

The Retina Module further expands the HRT II's clinical utility and is particularly useful for the location, quantification and tracking of Diabetic Macular Edema (DME), the largest cause of visual disability in G-8 countries. Presently 150 million people worldwide have diabetes, and that number may double within 25 years.(1)

The Retina Module has a unique method for creating edema maps, making non-invasive evaluation of diabetic patients easier. It may reduce the need for fluorescein fluorescein /flu·o·res·ce·in/ (fldbobr-res´en) a fluorescing dye; its sodium salt is used as a tracer in retinal angiography and as a diagnostic aid for revealing corneal trauma and fitting contact lenses.  images, and their associated patient risk and discomfort.

Lateral (X-Y) distribution of edematous e·dem·a·tous
adj.
Marked by edema.
 areas is now possible and a "9-Zone Analysis" feature based on the Early Treatment of Diabetic Retinopathy Study (ETDRS ETDRS Early Treatment Diabetic Retinopathy Study ) staging system -- a standard used for grading diabetic retinopathy progression -- is part of an elegant Trend Analysis which tracks disease progression and monitors treatment.

Dr. John Flanagan, of University of Toronto Research at the University of Toronto has been responsible for the world's first electronic heart pacemaker, artificial larynx, single-lung transplant, nerve transplant, artificial pancreas, chemical laser, G-suit, the first practical electron microscope, the first cloning of T-cells,  and University of Waterloo The University of Waterloo (also referred to as UW, UWaterloo, or Waterloo) is a medium-sized research-intensive public university in the city of Waterloo, Ontario, Canada. The school was founded in 1957. , said "Doctors have a unique opportunity to map and analyze early edema in their diabetic patients -- a disturbingly large and growing segment of the patient population."

Like the HRT II's glaucoma application, the Retina Module offers patients and doctors an impressive 3-D view -- an excellent patient education tool, which is an aid to better patient compliance.

The HRT II can also image other retinal pathologies such as macular holes and puckers, BRVO, age related macular degeneration and central serous retinopathy Central serous retinopathy (CSR), also known as central serous chorioretinopathy (CSC), is a visual impairment, often temporary, usually in one eye, affecting males in the age group 20 to 50. .

For additional information about the HRT II, please call 800-931-2230 (in the U.S.) or 760-598-3770 (outside of the U.S.).

(1) Zimmet, Alberti and Shaw. Nature. Dec. 2001.

Note: A photo is available at URL: http://www.businesswire.com/cgi-bin/photo.cgi?pw.110603/bb3
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 6, 2003
Words:382
Previous Article:Swiss Medica Enters Internet Marketing Partnership With Direct Response Interactive For O24 Pain Relief.
Next Article:vFinance Investments Forms Institutional Services Division.



Related Articles
New laser role for diabetes eyed. (using lasers on eyes of diabetics with macular edema)
Cold probe reduces preemie blindness.
Hypertension predicts diabetic eye-disease risk. (Biomedicine)
New treatments for macular degeneration.
Physicians find clues to vision deterioration.(research on age-related macular degeneration)(Brief Article)
ELECTRONICS MAY HOLD KEY TO RESTORING SIGHT.(News)(Statistical Data Included)
Diabetic eye disease: early detection crucial in preserving sight. (Advertising Supplement).(diabetic retinopathy)(Brief Article)(Statistical Data...
Adult stem cells form blood vessels. (Retina Rescue).(Brief Article)
ALLERGAN/SANWA KAGAKU KENKYUSHO TO DEVELOP POSURDEX IN JAPAN.
Dark side of a blood builder: hormone linked to diabetic blindness.(erythropoietin)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles